Form 8-K - Current report:
SEC Accession No. 0001493152-24-003336
Filing Date
2024-01-23
Accepted
2024-01-22 19:21:51
Documents
12
Period of Report
2024-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42249
  Complete submission text file 0001493152-24-003336.txt   211172

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tmbr-20240122.xsd EX-101.SCH 3027
3 XBRL LABEL FILE tmbr-20240122_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tmbr-20240122_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3035
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 24550191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)